28.11.2012 Views

Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...

Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...

Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

REFERENCES<br />

Lione A. (1983) The prophylactic reduction <strong>of</strong> alum<strong>in</strong>um <strong>in</strong>take. Food Chem. Toxicol. 21, 103–<br />

109.<br />

Lione A. (1984) Alum<strong>in</strong>um <strong>in</strong> foods. Nutr. Rev. 42, 31.<br />

Lione A. (1985) Alum<strong>in</strong>um toxicology and the alum<strong>in</strong>um-conta<strong>in</strong><strong>in</strong>g medications. Pharmacol.<br />

Ther. 29, 255–285.<br />

Litvan I., Bhatia K. P., Burn D. J., Goetz C. G., Lang A. E., McKeith I., Qu<strong>in</strong>n N., Sethi K. D., Shults<br />

C. and Wenn<strong>in</strong>g G. K. (2003) Movement Disorders Society Scientific Issues Committee<br />

report: SIC Task Force appraisal <strong>of</strong> cl<strong>in</strong>ical diagnostic criteria for Park<strong>in</strong>sonian disorders.<br />

Mov. Disord. 18, 467–486.<br />

Ljunggren K. G., Lidums V. and Sjögren B. (1991) Blood and ur<strong>in</strong>e concentrations <strong>of</strong> <strong>alum<strong>in</strong>ium</strong><br />

among workers exposed to <strong>alum<strong>in</strong>ium</strong> flake powders. Br. J. Ind. Med. 48, 106–109.<br />

López-Real A., Rey P., Soto-Otero R., Méndez-Álvarez E. and Labandeira-García J. L. (2005)<br />

Antiotens<strong>in</strong>-convert<strong>in</strong>g enzyme <strong>in</strong>hibition reduces <strong>oxidative</strong> <strong>stress</strong> and protects<br />

dopam<strong>in</strong>ergic neurons <strong>in</strong> a 6-hydroxydopam<strong>in</strong>e rat model <strong>of</strong> park<strong>in</strong>sonism. J. Neurosci.<br />

Res. 81, 865–873.<br />

Louis E. D., Marder K., Cote L., Wilder D., Tang M. X., Lantigua R., Gurland B. and Mayeux R.<br />

(1996) Prevalence <strong>of</strong> a history <strong>of</strong> shak<strong>in</strong>g <strong>in</strong> persons 65 years <strong>of</strong> age and older: diagnostic<br />

and functional correlates. Mov. Disord. 11, 63–69.<br />

Louis E. D., Tang M. X., Cote L., Alfaro B., Mejia H. and Marder K. (1999) Progression <strong>of</strong><br />

park<strong>in</strong>sonian signs <strong>in</strong> Park<strong>in</strong>son disease. Arch. Neurol. 56, 334–337.<br />

Luthman J., Fredriksson A., Sundström E., Jonsson G. and Archer T. (1989) Selective lesion <strong>of</strong><br />

central dopam<strong>in</strong>e or noradrenal<strong>in</strong>e neuron systems <strong>in</strong> the neonatal rat: motor behavior<br />

and monoam<strong>in</strong>e alterations at adult stage. Behav. Bra<strong>in</strong> Res. 33, 267–277.<br />

Mann V. M., Cooper J. M., Daniel S. E., Srai K., Jenner P., Marsden C. D., Schapira A. H. (1994)<br />

Complex I, iron, and ferrit<strong>in</strong> <strong>in</strong> Park<strong>in</strong>son’s disease substantia nigra. Ann. Neurol. 36, 876–<br />

881.<br />

215

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!